Nomura Holdings
STRO icon

Nomura Holdings’s Sutro Biopharma STRO Stock Holding History

Nomura Holdings’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,343
Closed -$127K – 1966
2024
Q2 		$127K Buy
+4,343
New +$172K ﹤0.01% 1673
2022
Q2 		– Sell
-12,513
Closed -$1.07M – 2137
2022
Q1 		$1.07M Sell
12,513
-9,630
-43% -$916K ﹤0.01% 1083
2021
Q4 		$3.3M Sell
22,143
-31
-0.1% -$5.55K 0.01% 841
2021
Q3 		$4.28M Buy
22,174
+20,924
+1,674% +$3.98M 0.01% 669
2021
Q2 		$233K Hold
1,250
– – ﹤0.01% 1702
2021
Q1 		$284K Hold
1,250
– – ﹤0.01% 1522
2020
Q4 		$272K Sell
1,250
-4,900
-80% -$811K ﹤0.01% 1345
2020
Q3 		$620K Buy
+6,150
New +$581K ﹤0.01% 934

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nomura Holdings's STRO Position: Q3 2024 in Review

Nomura Holdings sold out of Sutro Biopharma (STRO) in Q3 2024, closing a stake of 4,343 shares — an estimated $127K sold.

Nomura Holdings first reported a position in STRO in Q3 2020 and held it in 8 quarters. The position peaked at $4.28M in Q3 2021. 130 funds tracked by Wall St. Rank hold STRO as of Q3 2024.

  • Nomura Holdings reported no remaining Sutro Biopharma position as of Q3 2024 after selling out during the quarter.
  • Nomura Holdings sold 4,343 Sutro Biopharma shares in Q3 2024, an estimated $127K.
  • Nomura Holdings first reported a position in Sutro Biopharma in Q3 2020 and held it in 8 quarters.
  • Nomura Holdings's Sutro Biopharma position peaked at $4.28M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2024.

Based on Nomura Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.